Allspring Global Investments Holdings LLC reportedly made a new investment in Doximity, Inc. (NASDAQ: DOCS) during the third quarter, as stated in the most recent Form 13F filing that the company made with the Securities and Exchange Commission. This information is included in the filing that the company made. You can find it there. The company purchased 8,518 shares in the corporation for an investment of approximately $257,000.
A number of other hedge funds have followed suit and decreased the total amount of money they have invested in the company. Castle Wealth Management LLC began a new position in Doximity shares during the second quarter of the fiscal year. The shares had a value of approximately $31,000 when the investment was first made. Truvestments Capital LLC made a new investment in Doximity shares during the second quarter of the fiscal year. The shares had a value of approximately $32,000 at the time of the investment.
During the second quarter, Washington Trust Advisors Inc.
Increased 80.1% the proportion of Doximity stock it owned.
After making an additional purchase of 428 shares during the most recent quarter, Washington Trust Advisors Inc. now holds 962 shares of the company’s stock.
Each share of company stock is currently worth $33,000, and the company has 962 shares.
American International Group Inc.
Made a new investment in the amount of $43,000 during the second quarter for a position in Doximity.
Doximity received an investment of $51,000 from Geneos Wealth Management Inc.
During the first quarter of 2018. This is the last, but not the least, of the news. 52.48 hedge funds and other institutional investors own a percent of the total value of the stock.
On Thursday, the NASDAQ: DOCS stock began trading for the first time for $32.97. The price-to-earnings ratio for this company is 50.72; the price-to-earnings-to-growth ratio for this company is 17.56; and the beta value for this company is 0.86. The company’s total value, as measured by its market capitalization, is $6.35 billion. The stock’s simple moving average over the past fifty days is $33.36; its simple moving average over the past 200 days is $33.24.
Doximity, Inc. reached its all-time high of $64.95 in the past year, while the company hit its all-time low of $22.91 in the same period.
Doximity, Inc., which trades under the ticker symbol “NASDAQ: DOCS,” released its report on its performance on November 10. The company’s quarterly earnings per share came in at $0.12, which was in line with the average projection of $0.12 for the period. The company’s revenue for the period was also $0.12. The sales for the company for the quarter came in at $102 million, a significant increase from the $99.86 million analysts in the relevant industry had anticipated the company would make.
Doximity had a return on equity of 16.41%, and its net margin was 36.70%. The company’s overall profitability was excellent.
Doximity, Inc.
Is expected to generate earnings of $0.52 per share in 2018, according to analysts following the market.
DOCS has received comments on the findings of a variety of research companies. The price target that Wells Fargo & Company has set for Doximity shares has increased from $38.00 to $44.00, as stated in a research note published on Friday, November 11.
Additionally, the company gave the stock a rating of “overweight,” indicating that it is expected to perform well.
In a research note published on Friday, January 6, Morgan Stanley lowered its target price for Doximity from $32.00 to $29.00. The note was originally issued with a $32.00 target price.
In addition, the rating the firm had previously assigned to the company was altered from “equal weight” to “underweight.” Evercore ISI announced in a research note published on Friday, November 11, that they would increase their price objective for Doximity shares from $28.00 to $32.00.
Doximity shares were mentioned in a research note published by BTIG Research on Thursday, October 13. This note was the first time the company had discussed the shares. While evaluating the company, they decided to give it a ” neutral rating.” In a research note published on Friday, November 11, Piper Sandler announced that the price objective they set for Doximity shares had been reduced from $39.00 to $35.00.
Eight of the equity research experts have suggested purchasing the stock, three have suggested holding onto it, and two have suggested selling it.
According to the data retrieved from Bloomberg.com, the current rating that has been assigned to Doximity by the majority of analysts is “Hold,” and the average price objective assigned to the company is $41.40.
The digital platform managed by Doximity, Inc.
Is hosted in the cloud and is designed for use by medical professionals in the United States. The platform that the company offers gives its users access to tools designed specifically with the needs of medical professionals in mind. The platform that the company offers gives its users access to tools designed specifically with the needs of medical professionals in mind. These tools allow users to work together on patient care plans, manage their careers, stay current on the most recent medical research and news developments, and conduct virtual patient visits.